Improvement in health-related quality of life after treatment with resmetirom in patients with the spectrum of MASLD: From early MASH to MASH cirrhosis
Early MASH and MASH cirrhosis treated with resmetirom experience improvement in some disease-specific HRQL scores.
Authors
- Andrei Racila
- FATEMA NADER
- Maria Stepanova (ORCID: https://orcid.org/0000-0002-8385-4321)
- Dominic Labriola
- Rebecca Taub
- Zobair M Younossi
- Linda Henry
Institutions
- Inova Health System (US)
- Center for Outcomes Research in Liver Diseases (US)
- Global Health Council (US)
- Madrigal Pharmaceuticals (United States) (US)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1097/hc9.0000000000000913
- Citations
- 1
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 23.38